ISMICS 15 ISMICS 15 ISMICS 15
Exhibitors & Sponsors
 
 
Past Meetings
Future Meetings

Back to 2015 Annual Meeting Posters


Treatment of coronary artery disease (CAD) in TAVI patients: why, when, what to treat?
Tine E. Philipsen, MD, Johan M. Bosmans, MD, PhD, Guy D. Lenders, MD, Valérie M. Collas, MSc, Rodrigo A. Salgado, MD, Bernard P. Paelinck, MD, PhD, Inez E. Rodrigus, MD, PhD.
Antwerp University Hospital, Edegem, Belgium.

OBJECTIVE: CAD is a frequent concomitant pathology in patients with severe aortic valve stenosis. The timing of coronary intervention remains a point of discussion, as is the degree of invasiveness. Which lesions must we treat, and when should we do it? Is this treatment to be performed way in advance of the TAVI procedure, several days before or even after? Should we take into account the severity of anginous symptoms? Should we obtain new angiography images of these patients before continuing with the TAVI procedure?
METHODS: We evaluated all patients that underwent TAVI for CAD. Diagnosis was made based on coronary angiography. Symptomatology was recorded.
RESULTS: In our series of 200 consecutive TAVI procedures, 50% of patients had CAD as proven on angiography. 91% of them had been previously treated by means of PCI (52/100) and/or CABG (63/100). 28 patients were stented within 1 year before the TAVI procedure of which 21 patients within 3 months before TAVI (mean 82.5 days, range 20-280 days). 60.7% of the patients treated by PCI pré-TAVI were treated by BMS implantation. In 57.1%, either the LMCA, proximal/ mid LAD or proximal RCX were treated by PCI. In 3 patients, a stenotic vein graft after previous CABG was stented, while in 21.4%, more than one stenosis was treated. Analysis showed that previous PCI, either long term (between 1 year and 3 months) or shortly (within 3 months) before TAVI did not significantly influence procedural outcome nor 1 or 2 year survival, nor did the type of stent used (BMS versus DES).
CONCLUSIONS:
In our series of 200 consecutive TAVI procedures, the percutaneous treatment of CAD pré-TAVI did not influence survival. The question rises if we can postpone CAD treatment, even if the stenoses are significant, and first treat the aortic valve stenosis. Decision should be made based upon symptomatology, besides coronary imaging and echocardiography.


Back to 2015 Annual Meeting Posters
© 2026 International Society for Minimally Invasive Cardiothoracic Surgery. All Rights Reserved. Read Privacy Policy.